Technology areas: Biotechnology & Pharmaceuticals • Communications • Medical Devices & Mechanical Engineering
6 pending office actions • 4 clients • 6 examiners • 5 art units • 0 of 6 (0%) have an AI response strategy ready
Sci-Law Strategies, PC focuses on Biotechnology & Pharmaceuticals and has 5 pending office actions. The profile also records 367 career applications, indicating a smaller but measurable prosecution base.
The resolved allowance rate is 91.84%, and an allowance has required an average of 3.02 office actions. These results point to frequent allowance among resolved matters, with prosecution generally involving more than one examination exchange. Practitioners may view the profile as evidence of a strong resolution record alongside a manageable active docket.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (33%) |
| §112 only | 3 (50%) |
| No statute on record | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHERALI, ISHRAT I | 1 | 93.2% | +6.2% |
| WINDSOR, COURTNEY J | 1 | 86.3% | +9.0% |
| RICKS, DONNA J | 1 | 76.7% | +10.3% |
| DICKENS, AMELIA NICOLE | 1 | 47.2% | +21.6% |
| TOWA, RENE T | 1 | 49.5% | +17.5% |
| ALLEN, MARIANNE P | 1 | 60.1% | +18.4% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18984863 | AUTOMATIC IMAGE SEGMENTATION METHODS AND ANALYSIS | WINDSOR, COURTNEY J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17768138 | Natural non-pathogenic microorganisms capable of associating glycolipids or lipopeptides and use thereof | DICKENS, AMELIA NICOLE | 80d overdue |
| 18424594 | MULTI-USER MULTI-GPU RENDER SERVER APPARATUS AND METHODS | RICKS, DONNA J | 59d overdue |
| 16492987 | TARGET DETECTION USING A MONOVALENT ANTIBODY | ALLEN, MARIANNE P | 49d overdue |
| 17666730 | FRICTIONAL TISSUE SAMPLING AND COLLECTION METHOD AND DEVICE | TOWA, RENE T | — |
| Client (Assignee) | Pending OAs |
|---|---|
| PME IP PTY LTD | 3 |
| ACARYON GMBH | 1 |
| Histologics, LLC | 1 |
| NanoTag | 1 |
| Art Unit | Apps |
|---|---|
| 2667 | 1 |
| 2618 | 1 |
| 1645 | 1 |
| 3791 | 1 |
| 1647 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19030219 | APPARATUS AND METHOD FOR VISUALIZING DIGITAL BREAST TOMOSYNTHESIS AND OTHER VOLUMETRIC IMAGES | Pme Ip Pty Ltd. | SHERALI, ISHRAT I | 2667 | Other | Non-Final OA | — | Pending | Jan 17, 2025 |
| 18984863 | AUTOMATIC IMAGE SEGMENTATION METHODS AND ANALYSIS | Pme Ip Pty Ltd. | WINDSOR, COURTNEY J | §112 | Non-Final OA | — | Pending | Dec 17, 2024 | |
| 18424594 | MULTI-USER MULTI-GPU RENDER SERVER APPARATUS AND METHODS | Pme Ip Pty Ltd. | RICKS, DONNA J | 2618 | §103 | Final Rejection | 59d overdue | Pending | Jan 26, 2024 |
| 17768138 | Natural non-pathogenic microorganisms capable of associating glycolipids or lipopeptides and use thereof | Acaryon GmbH | DICKENS, AMELIA NICOLE | 1645 | §112 | Final Rejection | 80d overdue | Pending | Apr 11, 2022 |
| 17666730 | FRICTIONAL TISSUE SAMPLING AND COLLECTION METHOD AND DEVICE | Histologics, LLC | TOWA, RENE T | 3791 | §103 | Final Rejection | — | Pending | Feb 08, 2022 |
| 16492987 | TARGET DETECTION USING A MONOVALENT ANTIBODY | Nanotag Biotechnologies GmbH | ALLEN, MARIANNE P | 1647 | §112 | Final Rejection | 49d overdue | Pending | Sep 11, 2019 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial91.8% of resolved applications prosecuted by Sci-Law Strategies, Pc were allowed, across 367 applications in USPTO records.
3.02 office actions per allowed application on average.
6 pending office actions as of October 2026, for 4 clients, before 6 examiners in 5 art units.
